Human papillomavirus and lower genital neoplasia in renal transplant patients.
Lower genital cytopathology was evaluated in 105 immunosuppressed renal transplant recipients. Evidence of human papillomavirus infection was found in 17.5% and of lower genital neoplasia in 9.5%. The rate of the virus infection in the immunosuppressed was nine times greater than in a general population and 17 times greater than in a matched immunocompetent population. The rate of cervical neoplasia was 16 times greater than in a general population and nine times greater than in a matched immunocompetent population. In one-third of patients with human papillomavirus lesions and one-half of patients with neoplastic lesions, multiple lower genital sites were also involved. Of risk factors evaluated, only the number of sexual partners was associated with the development of human papillomavirus/lower genital neoplasia.
D000328:Adult; D005260:Female; D005833:Genital Neoplasms, Female / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D027383:Papillomaviridae / Q000302:isolation & purification; D012306:Risk; D012725:Sexual Behavior; D014412:Tumor Virus Infections / Q000453:epidemiology / Q000209:etiology*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000209:etiology; D014625:Vaginal Neoplasms / Q000453:epidemiology / Q000209:etiology; D014626:Vaginal Smears; D014846:Vulvar Neoplasms / Q000453:epidemiology / Q000209:etiology